GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties

SIMPLE SUMMARY: Glycogen synthase kinase-3 beta is a protein kinase implicated in the promotion and development of various cancers, including pancreatic cancer. In cell culture and animal studies, drugs targeting the inhibition of this protein show treatment potential in pancreatic cancer. Studies s...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Robin, Coveler, Andrew L., Cavalcante, Ludimila, Saeed, Anwaar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301062/
https://www.ncbi.nlm.nih.gov/pubmed/34356465
http://dx.doi.org/10.3390/biology10070610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301062/
https://www.ncbi.nlm.nih.gov/pubmed/34356465
http://dx.doi.org/10.3390/biology10070610

Ejemplares similares